Sio Gene Therapies Inc.

SIOX · NASDAQ
Analyze with AI
3/31/2022
3/31/2021
3/31/2020
3/31/2019
Operating Activities
Net Income-$72-$32-$73-$129
Dep. & Amort.$1$2$3$2
Deferred Tax$0-$11-$1$0
Stock-Based Comp.$7$4$8$16
Change in WC$4-$9-$3-$19
Other Non-Cash-$0-$1-$2-$5
Operating Cash Flow-$60-$47-$67-$134
Investing Activities
PP&E Inv.-$1-$0-$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$4$13$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$4$12-$0-$0
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$1$89$71$95
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$1$74$41$87
Financing Cash Flow$1$74$41$87
Forex Effect$0$0$0$0
Net Chg. in Cash-$55$39-$26-$47
Supplemental Information
Beg. Cash$120$81$107$154
End Cash$65$120$81$107
Free Cash Flow-$61-$47-$68-$134